Xizang Haisco Pharmaceutical Group Co Ltd Free Cash Flow Generation Index
Xizang Haisco Pharmaceutical Group Co Ltd free cash flow generation index. Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Free Cash Flow Generation Index of -0.83x as of September 2025. Free cash flow of CN¥-32.78 Million represents -1% of operating cash flow (CN¥39.68 Million). Check Xizang Haisco Pharmaceutical Group Co Lt liquidity resilience to evaluate the company's liquid asset resilience ratio.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Free cash flow generation index of Xizang Haisco Pharmaceutical Group Co Ltd from 2008 to 2025. Historical FCF Generation Index trend for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. Explore reinvestment intensity of Xizang Haisco Pharmaceutical Group Co Lt to see what proportion of operating cash flow is directed to capital expenditures.
Xizang Haisco Pharmaceutical Group Co Ltd Free Cash Flow Generation Index by Year (2008–2025)
Xizang Haisco Pharmaceutical Group Co Ltd free cash flow generation index by year from 2008 to 2025. Year-by-year Free Cash Flow Generation Index for Xizang Haisco Pharmaceutical Group Co Ltd. For the full cash flow conversion analysis, see cash flow conversion of Xizang Haisco Pharmaceutical Group Co Lt.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | CN¥454.03 Million | CN¥786.00 Million | CN¥331.98 Million | ▲ +18255.3% |
| 2024 | 0.00x | CN¥1.39 Million | CN¥442.05 Million | CN¥440.65 Million | ▼ -97.6% |
| 2023 | 0.13x | CN¥58.57 Million | CN¥449.58 Million | CN¥391.01 Million | ▲ +102.0% |
| 2022 | -6.41x | CN¥-605.62 Million | CN¥94.55 Million | CN¥700.17 Million | ▲ +65.6% |
| 2021 | -18.63x | CN¥-667.14 Million | CN¥35.80 Million | CN¥702.94 Million | ▼ -871.5% |
| 2020 | -1.92x | CN¥-395.51 Million | CN¥206.21 Million | CN¥601.72 Million | ▼ -907.3% |
| 2019 | 0.24x | CN¥181.58 Million | CN¥764.26 Million | CN¥582.68 Million | ▼ -6.9% |
| 2018 | 0.26x | CN¥120.62 Million | CN¥472.61 Million | CN¥351.98 Million | ▲ +7008.0% |
| 2017 | 0.00x | CN¥-1.45 Million | CN¥391.81 Million | CN¥393.26 Million | ▼ -100.7% |
| 2016 | 0.53x | CN¥217.87 Million | CN¥409.20 Million | CN¥208.24 Million | ▲ +48.0% |
| 2015 | 0.36x | CN¥159.35 Million | CN¥443.03 Million | CN¥283.68 Million | ▼ -32.5% |
| 2014 | 0.53x | CN¥267.71 Million | CN¥502.57 Million | CN¥234.86 Million | ▼ -25.1% |
| 2013 | 0.71x | CN¥404.43 Million | CN¥568.41 Million | CN¥163.98 Million | ▼ -2.6% |
| 2012 | 0.73x | CN¥339.45 Million | CN¥464.75 Million | CN¥125.30 Million | ▲ +33.1% |
| 2011 | 0.55x | CN¥143.07 Million | CN¥260.79 Million | CN¥117.72 Million | ▼ -29.6% |
| 2010 | 0.78x | CN¥286.43 Million | CN¥367.38 Million | CN¥80.95 Million | ▼ -16.6% |
| 2009 | 0.93x | CN¥344.21 Million | CN¥368.21 Million | CN¥24.01 Million | ▲ +54.7% |
| 2008 | 0.60x | CN¥57.07 Million | CN¥94.45 Million | CN¥37.38 Million | — |